Literature DB >> 9164443

Clinical promise of tumour immunology.

A M Scott1, J Cebon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164443     DOI: 10.1016/s0140-6736(97)90016-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.

Authors:  Andrzej Slominski; Blazej Zbytek; Radomir Slominski
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

2.  Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.

Authors:  Mara Giavina-Bianchi; Pedro Giavina-Bianchi; Mirian Nacagami Sotto; Alona Muzikansky; Jorge Kalil; Cyro Festa-Neto; Lyn M Duncan
Journal:  J Immunol Res       Date:  2015-04-14       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.